From August 30, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on September 18, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -3.55% | +5.43% | -49.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.63% | 28.39M | |
+16.45% | 122B | |
+21.96% | 116B | |
+25.15% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-15.94% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- Tranche Update on Enlivex Therapeutics Ltd.'s Equity Buyback Plan announced on September 18, 2023.